• Je něco špatně v tomto záznamu ?

Effect of ABCG2 on cytotoxicity of platinum drugs: interference of EGFP

M Ceckova, Z Vackova, H Radilova, A Libra, M Buncek, F Staud

. 2008 ; 22 (8) : 1846-1852.

Jazyk angličtina Země Velká Británie

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc11006306

Grantová podpora
1A8696 MZ0 CEP - Centrální evidence projektů

ATP-binding drug efflux transporters decrease intracellular concentrations of cytotoxic drugs, causing multidrug resistance in cancer. In this study, we examined possible interactions of ABCG2 transporter with platinum cytotoxic drugs. We demonstrate here an interference of platinum drugs with enhanced green fluorescence protein (EGFP) in the cellular models, where EGFP was employed as a reporter gene. Cytotoxicity of cisplatin (CIP), carboplatin (CAP) and oxaliplatin (OXP) was significantly lowered in MDCKII cells transfected with ABCG2 transporter and EGFP reporter. The IC(50) values in MDCKII-ABCG2 were 25.7, 164 and 165 microM for CIP, CAP and OXP, respectively, whereas IC(50) for the same cytostatics in MDCKII cells were as follows: 15.4, 133 and 50.3 microM. Addition of fumitremorgin C (FTC), a potent ABCG2 inhibitor, significantly suppressed the resistance of MDCKII-ABCG2 to OXP, suggesting that OXP interacts with ABCG2. However, FTC did not change the sensitivity of the cells to CIP and CAP. We assume that EGFP rather than ABCG2 causes the diminished toxicity of the platinum cytostatics in the transfected cells. This hypothesis was confirmed in human Hep2 cells expressing EGFP: using MTT test, IC(50) of 30.0, 247 and 27.9 microM were obtained for CIP, CAP and OXP, respectively, while 12.3, 106 and 20.5 microM were observed in the parent Hep2 cells. Employing neutral red cytotoxicity assay, similar data were obtained (IC(50) 7.73, 685 and 112 microM for CIP, CAP, and OXP, respectively, in the Hep2-EGFP cells and 1.65, 79.4 and 24.5 microM in the parent Hep2 cells). Caspase-3/7 assay revealed lower susceptibility of EGFP expressing Hep2 cells to apoptosis induced by CIP when compared to the parent cell line. We therefore conclude that EGFP in transfected cells interferes with cytotoxicity of platinum drugs by hindering the drug induced apoptosis and could cause misinterpretation of results obtained in cytotoxicity studies.

000      
04217naa 2200565 a 4500
001      
bmc11006306
003      
CZ-PrNML
005      
20140228114828.0
008      
110401s2008 xxk e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Čečková, Martina $7 xx0049092
245    10
$a Effect of ABCG2 on cytotoxicity of platinum drugs: interference of EGFP / $c M Ceckova, Z Vackova, H Radilova, A Libra, M Buncek, F Staud
314    __
$a Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Hradec Kralove, Czech Republic.
520    9_
$a ATP-binding drug efflux transporters decrease intracellular concentrations of cytotoxic drugs, causing multidrug resistance in cancer. In this study, we examined possible interactions of ABCG2 transporter with platinum cytotoxic drugs. We demonstrate here an interference of platinum drugs with enhanced green fluorescence protein (EGFP) in the cellular models, where EGFP was employed as a reporter gene. Cytotoxicity of cisplatin (CIP), carboplatin (CAP) and oxaliplatin (OXP) was significantly lowered in MDCKII cells transfected with ABCG2 transporter and EGFP reporter. The IC(50) values in MDCKII-ABCG2 were 25.7, 164 and 165 microM for CIP, CAP and OXP, respectively, whereas IC(50) for the same cytostatics in MDCKII cells were as follows: 15.4, 133 and 50.3 microM. Addition of fumitremorgin C (FTC), a potent ABCG2 inhibitor, significantly suppressed the resistance of MDCKII-ABCG2 to OXP, suggesting that OXP interacts with ABCG2. However, FTC did not change the sensitivity of the cells to CIP and CAP. We assume that EGFP rather than ABCG2 causes the diminished toxicity of the platinum cytostatics in the transfected cells. This hypothesis was confirmed in human Hep2 cells expressing EGFP: using MTT test, IC(50) of 30.0, 247 and 27.9 microM were obtained for CIP, CAP and OXP, respectively, while 12.3, 106 and 20.5 microM were observed in the parent Hep2 cells. Employing neutral red cytotoxicity assay, similar data were obtained (IC(50) 7.73, 685 and 112 microM for CIP, CAP, and OXP, respectively, in the Hep2-EGFP cells and 1.65, 79.4 and 24.5 microM in the parent Hep2 cells). Caspase-3/7 assay revealed lower susceptibility of EGFP expressing Hep2 cells to apoptosis induced by CIP when compared to the parent cell line. We therefore conclude that EGFP in transfected cells interferes with cytotoxicity of platinum drugs by hindering the drug induced apoptosis and could cause misinterpretation of results obtained in cytotoxicity studies.
590    __
$a bohemika - dle Pubmed
650    _2
$a ABC transportéry $x metabolismus $7 D018528
650    _2
$a zvířata $7 D000818
650    _2
$a protinádorové látky $x aplikace a dávkování $x farmakologie $x toxicita $7 D000970
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a karboplatina $x aplikace a dávkování $x farmakologie $x toxicita $7 D016190
650    _2
$a kultivované buňky $7 D002478
650    _2
$a cisplatina $x aplikace a dávkování $x farmakologie $x toxicita $7 D002945
650    _2
$a psi $7 D004285
650    _2
$a chemorezistence $7 D019008
650    _2
$a screeningové testy protinádorových léčiv $x metody $7 D004354
650    _2
$a zelené fluorescenční proteiny $x farmakologie $7 D049452
650    _2
$a lidé $7 D006801
650    _2
$a inhibiční koncentrace 50 $7 D020128
650    _2
$a biologické modely $7 D008954
650    _2
$a nádorové proteiny $x metabolismus $7 D009363
650    _2
$a organoplatinové sloučeniny $x aplikace a dávkování $x farmakologie $x toxicita $7 D009944
650    _2
$a transfekce $x metody $7 D014162
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vacková, Zuzana $7 xx0126212
700    1_
$a Radilová, Hana $7 mzk2006348915
700    1#
$a Libra, Antonín. $7 _BN007788
700    1_
$a Bunček, Martin, $d 1975- $7 mzk2006348916
700    1_
$a Štaud, František, $d 1970- $7 stk2007393932
773    0_
$t Toxicology in Vitro $w MED00004536 $g Roč. 22, č. 8 (2008), s. 1846-1852 $x 0887-2333
910    __
$a ABA008 $b x $y 2 $z 0
990    __
$a 20110414103904 $b ABA008
991    __
$a 20140228115642 $b ABA008
999    __
$a ok $b bmc $g 833908 $s 698402
BAS    __
$a 3
BMC    __
$a 2008 $b 22 $c 8 $x MED00004536 $d 1846-1852 $i 0887-2333 $m Toxicology in vitro $n Toxicol In Vitro
GRA    __
$a 1A8696 $p MZ0
LZP    __
$a 2011-1B09/jjme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...